These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

170 related articles for article (PubMed ID: 16061569)

  • 1. Novel RAG1 mutation in a case of severe combined immunodeficiency.
    Zhang J; Quintal L; Atkinson A; Williams B; Grunebaum E; Roifman CM
    Pediatrics; 2005 Sep; 116(3):e445-9. PubMed ID: 16061569
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Detection of RAG mutations and prenatal diagnosis in families presenting with either T-B- severe combined immunodeficiency or Omenn's syndrome.
    Tabori U; Mark Z; Amariglio N; Etzioni A; Golan H; Biloray B; Toren A; Rechavi G; Dalal I
    Clin Genet; 2004 Apr; 65(4):322-6. PubMed ID: 15025726
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Homozygous R396H mutation of the RAG1 gene in a Saudi infant with Omenn's syndrome: a case report.
    Al Balwi M; Al Ajaji S; Al Abdulkareem I; Hajeer A
    Cases J; 2009 Jul; 2():8391. PubMed ID: 19830075
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Relative CD4 lymphopenia and a skewed memory phenotype are the main immunologic abnormalities in a child with Omenn syndrome due to homozygous RAG1-C2633T hypomorphic mutation.
    McCusker C; Hotte S; Le Deist F; Hirschfeld AF; Mitchell D; Nguyen VH; Gagnon R; Mazer B; Turvey SE; Jabado N
    Clin Immunol; 2009 Jun; 131(3):447-55. PubMed ID: 19246248
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Restricted heterogeneity of T lymphocytes in combined immunodeficiency with hypereosinophilia (Omenn's syndrome).
    de Saint-Basile G; Le Deist F; de Villartay JP; Cerf-Bensussan N; Journet O; Brousse N; Griscelli C; Fischer A
    J Clin Invest; 1991 Apr; 87(4):1352-9. PubMed ID: 2010548
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A variant of SCID with specific immune responses and predominance of gamma delta T cells.
    Ehl S; Schwarz K; Enders A; Duffner U; Pannicke U; Kühr J; Mascart F; Schmitt-Graeff A; Niemeyer C; Fisch P
    J Clin Invest; 2005 Nov; 115(11):3140-8. PubMed ID: 16211094
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Mutations in the RNA component of RNase mitochondrial RNA processing might cause Omenn syndrome.
    Roifman CM; Gu Y; Cohen A
    J Allergy Clin Immunol; 2006 Apr; 117(4):897-903. PubMed ID: 16630949
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Analysis of mutations and recombination activity in RAG-deficient patients.
    Asai E; Wada T; Sakakibara Y; Toga A; Toma T; Shimizu T; Nampoothiri S; Imai K; Nonoyama S; Morio T; Muramatsu H; Kamachi Y; Ohara O; Yachie A
    Clin Immunol; 2011 Feb; 138(2):172-7. PubMed ID: 21131235
    [TBL] [Abstract][Full Text] [Related]  

  • 9. More than just SCID--the phenotypic range of combined immunodeficiencies associated with mutations in the recombinase activating genes (RAG) 1 and 2.
    Niehues T; Perez-Becker R; Schuetz C
    Clin Immunol; 2010 May; 135(2):183-92. PubMed ID: 20172764
    [TBL] [Abstract][Full Text] [Related]  

  • 10. GvHD-associated cytokine polymorphisms do not associate with Omenn syndrome rather than T-B- SCID in patients with defects in RAG genes.
    Haq IJ; Steinberg LJ; Hoenig M; van der Burg M; Villa A; Cant AJ; Middleton PG; Gennery AR
    Clin Immunol; 2007 Aug; 124(2):165-9. PubMed ID: 17572155
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Evolution of a T-B- SCID into an Omenn syndrome phenotype following parainfluenza 3 virus infection.
    Dalal I; Tabori U; Bielorai B; Golan H; Rosenthal E; Amariglio N; Rechavi G; Toren A
    Clin Immunol; 2005 Apr; 115(1):70-3. PubMed ID: 15870023
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Omenn syndrome: a disorder of Rag1 and Rag2 genes.
    Villa A; Santagata S; Bozzi F; Imberti L; Notarangelo LD
    J Clin Immunol; 1999 Mar; 19(2):87-97. PubMed ID: 10226883
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Clinical and genetic heterogeneity in Omenn syndrome and severe combined immune deficiency.
    Gruber TA; Shah AJ; Hernandez M; Crooks GM; Abdel-Azim H; Gupta S; McKnight S; White D; Kapoor N; Kohn DB
    Pediatr Transplant; 2009 Mar; 13(2):244-50. PubMed ID: 18822103
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Unusual clinical and immunologic manifestations of transplacentally acquired maternal T cells in severe combined immunodeficiency.
    Palmer K; Green TD; Roberts JL; Sajaroff E; Cooney M; Parrott R; Chen DF; Reinsmoen NL; Buckley RH
    J Allergy Clin Immunol; 2007 Aug; 120(2):423-8. PubMed ID: 17481714
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Omenn syndrome caused by a novel homozygous mutation in recombination activating gene 1.
    Benhsaien I; Essadssi S; Elkhattabi L; Bakhchane A; Abdelghaffar H; Bousfiha AA; Badou A; Barakat A
    Immunobiology; 2021 May; 226(3):152090. PubMed ID: 33964732
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Clinical phenotype and gene diagnostic analysis of Omenn syndrome].
    Wang YQ; Cui YX; Feng J
    Zhonghua Er Ke Za Zhi; 2013 Jan; 51(1):64-8. PubMed ID: 23527934
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Why newborn screening for severe combined immunodeficiency is essential: a case report.
    Adeli MM; Buckley RH
    Pediatrics; 2010 Aug; 126(2):e465-9. PubMed ID: 20603253
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Recombinase-activating gene 1 immunodeficiency: different immunological phenotypes in three siblings.
    Pasic S; Djuricic S; Ristic G; Slavkovic B
    Acta Paediatr; 2009 Jun; 98(6):1062-4. PubMed ID: 19243569
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Oligoclonal expansion of T lymphocytes with multiple second-site mutations leads to Omenn syndrome in a patient with RAG1-deficient severe combined immunodeficiency.
    Wada T; Toma T; Okamoto H; Kasahara Y; Koizumi S; Agematsu K; Kimura H; Shimada A; Hayashi Y; Kato M; Yachie A
    Blood; 2005 Sep; 106(6):2099-101. PubMed ID: 15845893
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Impaired CD4 and CD8 effector function and decreased memory T cell populations in ICOS-deficient patients.
    Takahashi N; Matsumoto K; Saito H; Nanki T; Miyasaka N; Kobata T; Azuma M; Lee SK; Mizutani S; Morio T
    J Immunol; 2009 May; 182(9):5515-27. PubMed ID: 19380800
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.